Clorox (NYSE:CLX) Announces Earnings Results

Clorox (NYSE:CLX) released its earnings results on Monday. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07, Zacks reports. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the previous year, the business earned $1.86 EPS. The business’s revenue was down 18.9% on a year-over-year basis. Clorox updated its FY 2026 guidance to 5.950-6.300 EPS.

Clorox Stock Performance

Clorox stock opened at $110.41 on Wednesday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The stock has a fifty day moving average price of $120.13 and a two-hundred day moving average price of $125.40. Clorox has a 52-week low of $107.71 and a 52-week high of $171.37. The firm has a market capitalization of $13.44 billion, a P/E ratio of 16.93, a P/E/G ratio of 0.92 and a beta of 0.52.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.5%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is currently 76.07%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CLX. The Goldman Sachs Group cut their price target on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $135.00 to $128.00 and set a “hold” rating for the company in a report on Monday, October 13th. UBS Group set a $119.00 target price on Clorox and gave the company a “neutral” rating in a research note on Tuesday. BNP Paribas Exane cut their target price on Clorox from $118.00 to $110.00 and set an “underperform” rating for the company in a research note on Friday, October 17th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $127.60.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.63% of the stock is owned by corporate insiders.

Institutional Trading of Clorox

Several large investors have recently made changes to their positions in CLX. Darwin Wealth Management LLC acquired a new position in shares of Clorox during the second quarter worth approximately $29,000. MUFG Securities EMEA plc acquired a new position in shares of Clorox during the second quarter worth approximately $44,000. State of Wyoming lifted its position in shares of Clorox by 4.7% during the second quarter. State of Wyoming now owns 2,540 shares of the company’s stock worth $305,000 after purchasing an additional 113 shares in the last quarter. Headlands Technologies LLC bought a new position in Clorox in the second quarter valued at about $437,000. Finally, Mendel Capital Management LLC boosted its holdings in Clorox by 4.7% in the second quarter. Mendel Capital Management LLC now owns 3,900 shares of the company’s stock valued at $468,000 after acquiring an additional 176 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.